Healthcare

The BHF responds to findings of the Section 59 Preliminary Report Investigations

Following the release of the Council for Medical Schemes’ (CMS) Section 59 Investigation Preliminary Report, Dr Katlego Mothudi, Managing Director of the Board of Healthcare Funders (BHF) said, “The BHF recognises the negative impact that the issues raised by the panel can have on the healthcare industry, and equally recognises the impact of fraud and corruption on the healthcare sector; and thus welcomed the processes undertaken by the CMS as we are of the view that these processes seek to ensure that stakeholders are aligned in purpose and do not engage in activities that may undermine the democratic processes that seek to support any interventions that prioritise and put the welfare and health of citizens first.”

Pandemic drives much-needed healthcare evolution

Section 59 Investigation Panel - Agreed Processes must be followed, before release of report

The Health Funders Association (HFA) is not party to the urgent court proceedings by GEMS and the Board of Healthcare Funders (BHF) to interdict the release of the Section 59 Investigation Panel’s Interim Report.

BHF member schemes confirm to fund Covid-19 vaccine, however, notes concerns

The Board of Healthcare Funders (BHF), a not-for-profit representative body of the healthcare funding industry, representing 56 medical schemes, administrators and managed care organisations have confirmed that it has been engaging with its members to chart a way forward on the R6.8 billion government has requested from medical schemes to fund the Covid-19 Vaccines.